14,15-Substituted lanosterols and their use as hypocholesterolemic agents
申请人:THE DU PONT MERCK PHARMACEUTICAL COMPANY
公开号:EP0276823A2
公开(公告)日:1988-08-03
Lanosterols substituted in the 14 and/or 15 position(s) which are active in inhibiting lanosta-8,24-dien-3β-ol 14α-methyl-demethylase activity, supressing 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity, decreasing cholesterol synthesis and reducing serum cholesterol levels are disclosed.